
Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer
Author(s) -
Evis Sala,
Maura Miccò,
Irene A. Burger,
Derya Yakar,
Marisa Kollmeier,
Debra A. Goldman,
Mithat Gönen,
Kay J. Park,
Nadeem R. AbuRustum,
Hedvig Hricak,
Hebert Alberto Vargas
Publication year - 2015
Publication title -
international journal of gynecological cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.901
H-Index - 87
eISSN - 1525-1438
pISSN - 1048-891X
DOI - 10.1097/igc.0000000000000519
Subject(s) - medicine , magnetic resonance imaging , cervical cancer , positron emission tomography , radiology , stage (stratigraphy) , univariate analysis , hazard ratio , confidence interval , proportional hazards model , concordance , retrospective cohort study , nuclear medicine , cancer , multivariate analysis , paleontology , biology
The aim of this study was to evaluate the incremental prognostic value of pelvic magnetic resonance imaging (MRI) and whole-body F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) findings compared with clinical-histopathologic factors in patients with newly diagnosed cervical cancer.